Ledger.Open graph →
SEC Form D · Amendment · filed December 31, 2014

PRIME GENOMICS, INC

Offering
$1.2M
Sold
$804K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert R. Tufts · SAN FRANCISCO, CADirector · PromoterPeter V. Groetzinger · SAN FRANCISCO, CAPromoterSandy C. Shaw · SAN FRANCISCO, CAExec · Director · PromoterThomas W. Loker · SAN FRANCISCO, CAExecAlan R. Brimm · SAN FRANCISCO, CAPromoterScott R. Greenstone · MILL VALLEY, CADirectorPenelope L. Pennington · Saint Louis, MOExecMichael P. Neely · New York, NYDirector · PromoterMarita A. Wein · Grand Cayman, Cayman IslandsExec · Director · PromoterKirk Galiani · McLean, VAPromoterMatthew A. Sharp · Old Lyme, CTPromoterRobert L. Thomas · London, United KingdomDirectorRaymond C. Merritt · Berwyn Heights, MDDirector · PromoterJames A. Tricarico, Jr · Saint Louis, MOExec · Director · PromoterKevin D. Bastien · Saint Louis, MOExecLancaster Investment Management LLP · London, United KingdomDirectorMark D. Fisher · McLean, VAPromoterTimothy Roche · San Diego, CAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗